Status:
COMPLETED
Defining an Immunological Signature Related to Lesion Location in Multiple Sclerosis
Lead Sponsor:
Rennes University Hospital
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
The objective of APOLLO is therefore to identify biomarkers associated with the CNS involvement phenotype in early MS patients.
Detailed Description
This is a multicenter, non-interventional, retrospective cohort study. In MS patients, a recent study suggests that the location of lesions in the brain relative to the ME is associated with different...
Eligibility Criteria
Inclusion
- Patients with clinically isolated syndrome (CIS) participating in the OFSEP cohort (French MS Observatory)
- At least 18 years old
- Diagnosed with MS according to the 2017 criteria at the time of their last visit
- Not opposed to participating in the study
- Had at least one visit in the year following sampling
- Followed up for at least 1 year after collection.
- Signed OFSEP consent form
Exclusion
- CIS patients with progressive MS
Key Trial Info
Start Date :
March 9 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 9 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05326048
Start Date
March 9 2022
End Date
September 9 2022
Last Update
March 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University hospital of Rennes
Rennes, France, 35000